Does the SLC30A8 rs13266634 C allele increase type 2 diabetes risk by impairing beta-cell zinc transport?

Genetic research into the SLC30A8 gene has identified the rs13266634 polymorphism as a critical determinant of pancreatic beta-cell function and type 2 diabetes (T2D) susceptibility. The rs13266634 variant results in an amino acid substitution (Arg325Trp) in the Zinc Transporter 8 (ZnT8) protein, which is localized specifically to insulin secretory granules.

Clinical and genetic evidence

The association between the SLC30A8 rs13266634 C allele (encoding Arg325) and T2D risk is robustly supported by large-scale genome-wide association studies (GWAS) and meta-analyses.

• Risk Association: The C allele is consistently identified as the risk-conferring variant across multiple ethnicities, including European and East Asian populations. Meta-analyses report an odds ratio (OR) for T2D susceptibility ranging from 1.15 to 1.23 per C allele.
• Genotype Impact: Individuals carrying the CC genotype face a significantly higher risk (OR ~1.51) compared to those with the protective TT genotype.
• Beta-cell Function: Clinical assessments using the Homeostatic Model Assessment of Beta-cell function (HOMA-B) indicate that risk allele carriers exhibit significantly lower insulin secretion capacity, whereas insulin sensitivity (HOMA-IR) typically remains unaffected.

Mechanistic explanations

The increased risk associated with the C allele is driven by a well-defined molecular mechanism involving zinc homeostasis within the pancreas.

• Zinc Transport Efficiency: The ZnT8 protein is responsible for transporting zinc ions (Zn²⁺) from the cytoplasm into insulin secretory granules. Functional assays in clonal beta-cells and proteoliposomes demonstrate that the risk C allele (Arg325) is associated with reduced zinc transport activity compared to the tryptophan (Trp325) variant.
• Insulin Hexamerization: Zinc is essential for the maturation of insulin; six insulin molecules must bind with two zinc ions to form stable hexamers. This crystallization is required for the formation of dense-core secretory granules.
• Secretory Deficits: Reduced zinc transport leads to lower intra-granule zinc concentrations, resulting in atypical or immature insulin crystals. This structural defect impairs glucose-stimulated insulin secretion (GSIS), particularly the rapid first-phase insulin release necessary for postprandial glucose control.

Bottom line

The SLC30A8 rs13266634 C allele is a high-confidence genetic risk factor for type 2 diabetes. It functions by reducing the efficiency of ZnT8-mediated zinc transport, which destabilizes insulin storage and impairs the beta-cell's ability to secrete insulin in response to glucose.